RVU120 Rollover Study

Clinical trial NCT06987058 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06987058
Sponsor: Ryvu Therapeutics SA
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Acute Myeloid Leukaemia (AML)High-risk Myelodysplastic Syndrome

Start date: 2025-12-04
Primary completion: 2026-08-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.